Commercialdiligence · Newsroom
BiopharmaVantage discusses DCF valuation in the healthcare and life sciences sector
Valuation often happens to be the most widely discussed topic in several conferences and forms many research theses. Currently, DCF and comparables based methods are mostly employed valuation methods.October 20, 2017
BiopharmaVantage discusses the quality of competitive intelligence in the pharmaceutical industry
The insights gathered from competitive intelligence (CI) engagements are intelligence not data, thus CI based insights are not amenable to most quantitative methods.September 14, 2017
BiopharmaVantage the specialist Healthcare and Life Sciences Commercial Due Diligence firm advises on the Investment in an Immunotherapy Business
BiopharmaVantage, the specialist Healthcare and Life Sciences Commercial Due Diligence firm, advises on the Investment in an Immunotherapy BusinessSeptember 8, 2017
Biosimilars Competitive Intelligence in the Pharmaceutical and Biotechnology Industry
Biosimilars Competitive Intelligence in the Pharmaceutical and Biotechnology Industry
August 21, 2017